By Ben Hirschler LONDON, April 29 (Reuters) - An antiseptic gel to stop umbilical cord infections in newborn babies was recommended as safe and effective by European regulators on Friday in a boost for GlaxoSmithKline scientists who developed it from a mouthwash. The British drugmaker
Read moreBy Ben Hirschler LONDON, April 27 (Reuters) - It has been one of the pharmaceutical industry's most closely watched experiments: does ending payments to doctors undermine drug sales? GlaxoSmithKline, the British drugmaker, believes it has proved that raising the ethical bar on marketi
Read more* Higher margins and new drugs help company beat forecasts * New CEO expected to be named towards end of 2016 * First-quarter core EPS 19.8 pence vs consensus 17.9p * Q1 sales 6.23 billion pounds vs consensus 6.01 billion * Shares up 2.7 pct at 1230 GMT (Adds more on CEO
Read more(ShareCast News) - GlaxoSmithKline posted a rise in first-quarter sales and core earnings per share amid healthy demand for the company's new drugs. First-quarter sales were up 11% in sterling terms to £6.2bn, with core earnings per share 14% higher at 19.8p, beating analysts' forecasts of 17.9p. N
Read moreLONDON, April 27 (Reuters) - Improving margins in consumer health and growing demand for new drugs helped lift GlaxoSmithKline's underlying earnings a better-than-expected 14 percent in the first quarter, keeping it on course to achieve a promised return to growth in 2016. The British drugm
Read more(ShareCast News) - The FTSE 100 was treading water on Tuesday afternoon, managing to keep itself in the black in contrast to its sibling index. Emerging markets-exposed bank Standard Chartered was among the top performers, as investors showed their approval of the bank's ongoing turnaround. It poste
Read more